Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,232.00
(
0.41%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
101.33
(
0.67%
)
Bitcoin
73,040.62
(
-1.22%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 91920

Thursday, 01/24/2013 7:06:21 PM

Thursday, January 24, 2013 7:06:21 PM

Post# of 257253
BMY reneged on its 2013* EPS guidance of $1.95+ given 3 years ago (#msg-47502391); the 2013 (non-GAAP) EPS guidance issued today is $1.78-$1.88:

http://finance.yahoo.com/news/bristol-myers-squibb-reports-fourth-123000706.html

However, investors didn’t seem to mind; BMY was +3% today and is trading close to an 11-year high.

*The first full year after the loss of exclusivity on Plavix.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now